ConductScience.org, home

Paper15565409

Development and evaluation of FSSG: frequency scale for the symptoms of GERD.

Kusano M and 14 others. J Gastroenterol, 2004. Cited by 400 papers, by iCite.

Cite this record

ConductScience Library. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. Papers, record 15565409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15565409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development and evaluation of FSSG: frequency scale for the symptoms of GERD.
PubMed
Journal
J Gastroenterol
PubMed
Year
2004
PubMed
Publication types
Evaluation Study, Journal Article
PubMed
Citations, by iCite
400
iCite
Relative citation ratio, by iCite
12.9
iCite
Revised in PubMed
2022-04-09
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kusano MMotoyasu
2Shimoyama YYasuyuki
3Sugimoto SSayaka
4Kawamura OOsamu
5Maeda MMasaki
6Minashi KKeiko
7Kuribayashi SShiko
8Higuchi TTatsuya
9Zai HHiroaki
10Ino KKyoko
11Horikoshi TTsutomu
12Sugiyama TTadashi
13Toki MMunetoshi
14Ohwada TTsuneo
15Mori MMasatomo

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastroesophageal RefluxMajor topic
Surveys and QuestionnairesMajor topic
Endoscopy, Gastrointestinal
Humans
Sensitivity and Specificity

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04028466Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm FeaturesBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by233

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 400 citations.

PMIDTitleJournalYearIn PapersSource
42923836Real-time tele-endoscopic guidance for endoscopic antireflux mucosectomy using a novel high-speed mobile network system.VideoGIE2026https://conductscience.org/library/papers/42923836PubMed
42677194Clinical Utility of Anti-reflux Mucosal Intervention for Refractory Gastroesophageal Reflux Disease in Patients With a Hiatal Hernia.DEN Open2027https://conductscience.org/library/papers/42677194PubMed
42609230Vietnam Association of Gastroenterology (VNAGE) guideline on the management of gastroesophageal reflux disease.Front Med (Lausanne)2026https://conductscience.org/library/papers/42609230PubMed
42367300Pharmacological safety and real-world efficacy of the potassium-competitive acid blocker fexuprazan in cardiovascular patients receiving antithrombotic therapy: a prospective cohort study (FEXGARD).Front Pharmacol2026https://conductscience.org/library/papers/42367300PubMed
42295204Efficacy and Safety of Closure-Focused Anti-Reflux Mucoplasty Compared With Conventional ARMS: A Propensity Score-Matched Study (With Video).Dig Endosc2026https://conductscience.org/library/papers/42295204PubMed
42224288Gastroesophageal reflux symptoms and sleep quality among medical students at a private university in Lima, Peru: A cross-sectional study.PLoS One2026https://conductscience.org/library/papers/42224288PubMed
42052602Efficacy and safety of potassium-competitive acid blockers in eradicating Helicobacter pylori and treating gastro-esophageal reflux disease: A systematic review and meta-analysis.Caspian J Intern Med2026https://conductscience.org/library/papers/42052602PubMed
42022439Sleep Bruxism and Gastroesophageal Reflux. A Scoping Review.Nat Sci Sleep2026https://conductscience.org/library/papers/42022439PubMed
41998585Determinants of high chronic obstructive pulmonary disease assessment test scores according to airflow limitation severity: a three-year prospective study.BMC Pulm Med2026https://conductscience.org/library/papers/41998585PubMed
41680582Patient-Reported Outcome Measures Used in Primary Hyperparathyroidism: A Scoping Review.Ann Surg Oncol2026https://conductscience.org/library/papers/41680582PubMed
41631046Evaluating the Frequency of Esophageal Motility Disorders in Patients With Upper Gastrointestinal Symptoms Based on the Chicago Classification Version 3.0.Cureus2026https://conductscience.org/library/papers/41631046PubMed
41473024The Prevalence of Esophageal Hypomotility and Its Relationship With Dysmotility Score in Vietnamese Patients Having Reflux Symptoms.JGH Open2025https://conductscience.org/library/papers/41473024PubMed
41141107Association Between Gastroesophageal Reflux Disease Severity and Depression and Anxiety in Young Adults: A Cross-Sectional Study.Cureus2025https://conductscience.org/library/papers/41141107PubMed
41013293Associations between socio-demographic factors, social functioning, and sleep quality among GERD patients in Syria: a cross-sectional study.BMC Gastroenterol2025https://conductscience.org/library/papers/41013293PubMed
40969410
Comparison the effect of Asvard capsule and omeprazole in treatment and recurrence of non-cardiac chest pain related to gastroesophageal reflux disease in adults: A controlled double blind clinical trial.
Avicenna J Phytomed2025https://conductscience.org/library/papers/40969410PubMed
40949009Characteristics of patients with systemic sclerosis with aspiration: A single-center study.J Scleroderma Relat Disord2025https://conductscience.org/library/papers/40949009PubMed
40777627Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease.Biomed Rep2025https://conductscience.org/library/papers/40777627PubMed
40776684Effectiveness of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors on Esophageal Wall Thickening in Eosinophilic Esophagitis.Gut Liver2026https://conductscience.org/library/papers/40776684PubMed
40735551Step-Down Therapy Using Vonoprazan for Giant Gastric Polyps in Long-Term Proton Pump Inhibitor Administration.Case Rep Gastroenterol2025https://conductscience.org/library/papers/40735551PubMed
40630384Real-world usage and response to gefapixant in refractory chronic cough.ERJ Open Res2025https://conductscience.org/library/papers/40630384PubMed

See all 233 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15565409

GET https://conductscience.org/api/papers/v1/15565409/cited_by?page=2